✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals

Lasa Supergenerics Ltd.

LASA

Market Cap
₹90 Cr.
P/E
0.00

Lasa Supergenerics Ltd.

  • Lasa Supergenerics
  • Mangalam Drugs&Org.
  • Smruthi Organics
FAQs on Lasa Supergenerics Ltd. Shareprice

Lasa Supergenerics has given lower returns compared to its competitors.
Lasa Supergenerics has grown at ~-19.56% over the last 7yrs while peers have grown at a median rate of 5.41%

Lasa Supergenerics is not expensive.
Latest PE of Lasa Supergenerics is 0.0, while 3 year average PE is 3.61.
Also latest EV/EBITDA of Lasa Supergenerics is 0.0 while 3yr average is 20.74.

View FAQ's On Business
Growth Table
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Smruthi Organics
Balance Sheet
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Smruthi Organics
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Smruthi Organics
Cash Flow
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Smruthi Organics
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Smruthi Organics
Quarterly Results
  • Lasa Supergenerics Ltd.
  • Mangalam Drugs&Org.
  • Smruthi Organics
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
*Implied Growth calculated using Newton-Rhapson method.
Learn how to use Reverse DCF
FAQs on Lasa Supergenerics Ltd. Financials

Balance sheet of Lasa Supergenerics is moderately strong, But short term working capital might become an issue for this company.

The debt of Lasa Supergenerics is decreasing.
Latest debt of Lasa Supergenerics is ₹19.11 Crs as of Sep-24.
This is less than Mar-24 when it was ₹19.18 Crs.

Yes, profit is increasing.
The profit of Lasa Supergenerics is -₹15.77 Crs for TTM, -₹21.73 Crs for Mar 2024 and -₹38.62 Crs for Mar 2023.

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
Lasa Supergenerics latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

View FAQ's On Shareholding
Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech